Restoration Group plans to invest A$1.6m in Biosignal

Published: 17-Aug-2006


Japanese Restoration Group is to invest up to A$1.6m in Australian company Biosignal.

Restoration has identified the field of biomimicry as a key investment target. Biosignal, whose antibacterial technology is based on models from marine organisms, is a classic case of biomimicry and is one of Restoration’s first investments in this field. Restoration expects to make a dozen additional investments over the next few years.

The investment by Restoration is not aimed specifically at activities in Japan but is designed to drive Biosignal’s global business success. However, the initial focus will be on opportunities in Japan. Restoration expects to provide further resources, in addition to the equity investment, to promote the development and launch of products based on Biosignal’s technology in Japan.

Biosignal and Restoration will initially focus Japanese activities on a suite of industrial products aimed at biofilm prevention and removal in different product applications in the housing and construction sector.

Biosignal and Restoration have also agreed to assess manufacturing of Biosignal’s compounds in Japan.

Biosignal’s antibiofilm technology is based on a discovery that the eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacteria’s ability to colonise. Bacteria rapidly produce resistant strains when faced with strong selective pressure by killing agents or growth-inhibitory agents. Furanones lull bacteria to inaction and appear to avoid the problem of bacterial resistance.

Biosignal produces synthetic compounds effective on inanimate surfaces such as pipes, membranes and medical devices; and animate surfaces such as lungs, skin and teeth. The first application of its novel antibacterial technology is reducing risks of infection from contact lenses.

See more

You may also like

Analysis

The case for a facility monitoring system

Read more
In regulated manufacturing, monitoring environmental conditions and critical equipment is essential to protect product quality, yield, and patient safety. Facilities often use a Facility Monitoring System (FMS) to track factors like airborne particles, temperature, and humidity. Beyond regulatory compliance, FMS delivers real business value through reduced waste, improved yield, higher quality, and greater profitability

Trending Articles

  1. AdvanceTEC drives cleanroom innovation & growth with acquisition by Equans Leveraging scale, global reach, technology, prefabrication & modularisation
  2. Medicinal cannabis production with GMP-compliant cleanroom solutions Controlled environments are supporting quality, safety and regulatory compliance in cannabis manufacturing
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    President Trump signs order for “regulatory relief” for domestic pharmaceutical manufacturers The US President has signed an executive order to direct the FDA to review current regulatory procedures, such as by reducing inspection frequency
  4. Pharmaceutical carbon reduction expert EECO2 achieves B Corp status A relatively unique certification in the cleanroom design industry, EECO2 has been determined to meet the necessary high standards of social and environmental performance, transparency, and accountability for B Corporation status
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrating “high-voltage leak detection” into automated visual inspection Leoni Ransmann and Jan Sende from Syntegon Technology talk about visual inspection of product containers like ampoules, which has been the industry standard for decades, and compare it to modern methods being emphasised in documents like the new EU GMP Annex 1

Upcoming event

Cleanzone Middle East

September 18-19 2025 | Conference | Conrad Dubai, United Arab Emirates See all

You may also like

Analysis

The case for a facility monitoring system

In regulated manufacturing, monitoring environmental conditions and critical equipment is essential to protect product quality, yield, and patient safety. Facilities often use a Facility Monitoring System (FMS) to track factors like airborne particles, temperature, and humidity. Beyond regulatory compliance, FMS delivers real business value through reduced waste, improved yield, higher quality, and greater profitability
Pharmaceutical

300 hours of performance with APSPG-Max

NewAge Industries, Inc., parent company of the AdvantaPure™ line of tubing, hose and quality accessories for the high-purity market, announces the launch of its’ newest line of tubing, AdvantaSil APSPG-Max silicone pump tubing
Design & Build

Kemtile to showcase single source flooring solutions at PPMA 2025

Kemtile is using PPMA 2025 to engage prospective customers on the benefits of coming to an internationally-backed industrial flooring and drainage business with a single source approach to flooring projects across the process and packaging industry
Pharmaceutical

Steriline at CPHI 2025

Flexibility, robotics and customisation for a zero loss approach
Design & Build

AdvanceTEC drives cleanroom innovation & growth with acquisition by Equans

Leveraging scale, global reach, technology, prefabrication & modularisation
Pharmaceutical

Steriline at Pharma Pro&Pack Expo 2025

With its own branch already established in India, Steriline confirms the importance of the Indian and of Asian markets in general for its growth and development
Design & Build

Preserve and protect your cleanroom with a Guardtech Group Cleanroom Service Plan

Suffolk-based construction experts offering elite packages to ensure all service, maintenance and decontamination needs are taken care of
Subscribe now